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ABSTRACT 
Background Hospital and community pharmacists are increasingly involved in patients’ medication interventions related to the 
transition of care from the hospital to a patient’s home. These interventions may enable pharmacists to collaborate across healthcare 
sector boundaries. However, little is known about pharmacists’ views on intraprofessional collaboration across healthcare sectors and 
what affects the establishment of such collaboration. 
Objectives The aim of this study was to understand the views and perspectives of hospital pharmacists (HPs) and community 
pharmacists (CPs) on establishing an intraprofessional collaboration in relation to newly discharging patients.  
Methods Joint focus group interviews with HPs and CPs in the Zealand region of Denmark were conducted. The HPs were employed at 
the only hospital pharmacy in the region (Region Zealand Hospital Pharmacy). Five HPs and six CPs participated in two focus groups. 
The focus groups were analyzed using theoretical thematic analysis. 
Results Three themes and seven subthemes were identified. The first theme, “Context”, was divided into two subthemes: “Prioritization 
of new tasks in the intraprofessional collaboration” and “The lack of insight into the patient’s hospital stay”. The second theme, “The 
hospital physicians and GPs as the focal points for the HPs’ and CPs’ work”, was divided into three subthemes: “The limitation of the 
CPs and HPs based on current roles and organizations”, “Lack of regular access to the physician gives the patients more responsibility” 
and “Lack of support from the GPs for the work conducted by HPs and CPs”. The last theme, “Individuals”, had two subthemes: “The 
motivation for working intraprofessionally” and “CPs’ hesitancy towards the new tasks in the intraprofessional collaboration”.  
Conclusion Both HPs and CPs are highly influenced by their work context in regard to establishing a new intraprofessional collaboration. 
Limited resources for intraprofessional collaboration should be taken into account. Likewise, the collaboration should fit into daily 
routines, which may eliminate hesitancy towards new forms of collaboration and tasks shared between HPs and CPs. The physician 
was identified as an important key professional, since the work tasks of both HPs and CPs depend on the physician, which in turn limits 
the capability and success of solely intraprofessional collaboration. 
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INTRODUCTION 
The transition of care is a critical point for patient medication 
safety, especially when patients are discharged from the 
hospital to primary care [1–7]. The decision to discharge a 
patient resides in the hospital, and a majority of studies 
published have been hospital-based and have sometimes 
included hospital pharmacists (HPs) [8–12]. The pharmacist’s 
role in optimizing the transition of care has been well studied, 
and among other things, the studies highlight close 
collaboration with other professions as a pivotal component in 
creating safe transitions for patients [13–16]. One way of 
securing a seamless transition of care is through pharmacist 
involvement in multidisciplinary care teams collaborating with 
other professions, in particular hospital physicians and general  
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practitioners (GPs) [9,17]. The pharmacist’s role in 
multidisciplinary teams includes acting as the medication 
expert, providing advice, and suggesting interventions for how 
to secure rational pharmacotherapy and patient safety. This 
involvement and interprofessional collaboration have yielded 
significant positive effects on both clinical endpoints, especially 
hard endpoints such as hospital readmissions [18–20]. 
Interprofessional collaboration with physicians is slowly 
becoming well established in some countries in hospitals and 
GP practices. Gobis et al., however, suggest that more research 
should be conducted in the field of intraprofessional 
pharmacist-to-pharmacist collaboration, especially at transition 
of care points, to avoid a fragmented pharmaceutical approach 
to patient care [21]. 
 
Few studies have described interventions involving 
intraprofessional collaboration between hospital and 
community pharmacists. These interventions involve 
information sharing regarding medication changes and relevant 
patient information from the HPs to the community 
pharmacists (CPs), enabling the CPs to gain access to relevant 
information needed to inform newly discharged patients. The 
information sharing either resulted in a new intervention 
conducted for the patients at the community pharmacy or in 
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improved counselling of the patients at the community 
pharmacy  [10,22–26].  
 
In a survey conducted by the European Association of Hospital 
Pharmacists (EAHP) it was concluded that more than half of the 
CPs had never been contacted by an HP, and over half of both 
HPs and CPs found it either essential or important to 
collaborate at especially transition of care points [27]. Thus, 
there is a demand expressed by both HPs and CPs for more 
intraprofessional collaboration. However, literature is lacking in 
relation to understanding HPs’ and CPs’ views and perspectives 
on establishing such intraprofessional collaboration at care 
transitions. Understanding the views and perspectives of HPs 
and CPs might shed light on existing barriers or facilitators that 
can affect the feasibility of intraprofessional collaboration in a 
cross-sector setting.  
 
In Denmark, HPs are involved in various parts of the patient’s 
hospital stay, at admission, during the hospital stay and at 
discharge, performing a broad range of services, such as 
medication reviews, medication reconciliation and discharge 
conversations. This study is a part of a larger study conducted 
within Region Zealand in Denmark. In Region Zealand, HPs are 
routinely involved in admission of patients on the acute wards, 
where they compile medication history and conduct a 
medication reconciliation and a medication review [28]. In 
Region Zealand, HPs do not routinely take part in discharging 
patients nor do they routinely collaborate or send information 
directly to the CPs at the community pharmacy. Thus, this study 
explores the views and perspectives of CPs and HPs on a new 
potential intraprofessional collaboration.  
 
OBJECTIVE(S) 
The aim of this study was to understand the views and 
perspectives of hospital pharmacists (HPs) and community 
pharmacists (CPs)….on….establishing an intraprofessional 
collaboration concerning newly discharged patients.  
 
ETHICS APPROVAL 
Since participation in the focus groups involved recording of 
personal data (e.g., age, gender workplace and work 
experience), permission for the study was obtained from the 
Danish Data Protection Agency through the Faculty of Health 
and Medical Sciences, University of Copenhagen, with 
reference number: 514-0264/18-3000. 
 
METHODS 
An explorative qualitative design comprising focus group 
interviews was chosen. Focus group interviews are especially 
suitable for grasping the joint perspectives and reflections of a 
specific population [29,30]. Additionally, the interaction 
between participants stimulates discussions in a natural way, a 
feature specifically useful when exploring the opinions of the 
two groups of pharmacists (HPs and CPs), who are not 
collaborating already [29]. 
 
Setting 
The study was conducted in Region Zealand in Denmark which 
covers 38 community pharmacies. The community pharmacies 
offer free services for patients, for example, medication 
conversation, which is a consultation service for patients being 
prescribed medicine for a newly diagnosed chronic disease or 
for medication non-adherent chronic medication-users [31]. 
The medication conversation was developed in England as a so-
called “New medicine-service” and is described in more detail 
in the protocol by Boyd. et al. [32]. 
 
Region Zealand has one regional hospital pharmacy. The 
pharmacy provides medication and clinical pharmacy services 
to the eight hospitals in the region as well as the psychiatric 
hospital. One of the clinical pharmacy services conducted by 
HPs is the clinical pharmacist service (CPS). The CPS consists of 
a pharmacist compiling the medication history, medication 
reconciliation and medication review [28]. Pharmacist 
interventions following the service are documented in the 
patient’s health record as a pharmacist note. Because 
collaboration between admission HPs and CPs does not yet 
exist in Region Zealand, it was deemed necessary to propose a 
way for the HPs and CPs to work together in relation to 
discharged patients and use this cooperation as an offset for 
discussion in the focus group interviews (see figure 1). 
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Figure 1: The proposed setup of an intraprofessional cross-sector collaboration between hospital and community pharmacists, as it was 
visually presented for the focus group participants. A pharmacist note is a note registered by a clinical pharmacist in the patient’s electronic 
health record after conducting a medication review. It includes suggestions for interventions regarding medical treatment.  
Participants 
A purposeful sampling method was used, inviting HPs providing 
the CPS from the Region Zealand Hospital Pharmacy and CPs 
from all community pharmacies in the region [33]. Thirteen HPs 
and 38 CPs were invited to participate. Six HPs and nine  
CPs signed up to participate, allowing for two focus group 
interviews. Five HPs and six CPs were able to attend either of 
the two focus group interviews. The focus group interviews 
aimed at an equal distribution of HPs and CPs in each group 
[32]. LVJL facilitated both focus groups, while LSN moderated, 
took notes and observed the participants during the interview 
and made debriefing interviews with LVJL following each focus 
group interview. 
  
Data collection 
The focus groups were audio-recorded. Informed consent was 
signed by each participant before the groups were formed. A 
semi-structured interview guide based on an inductive 
approach was used (See Appendix I). The wording of the 
questions and the setup followed the focus group interview 
guide by Huston et al. [32]. Since the focus groups consisted of 
a mix of HPs and CPs, an “ice breaking” session was added at 
the beginning of the focus group (Section 2), allowing the 
participants to establish common ground (See Appendix I).   
 
Data analysis 
Audio recordings from both focus groups were transcribed 
verbatim. NVivo 10 (QSR International Pty Ltd, Australia) guided 
both the transcription and the analysis of the data. The data 
were analyzed using thematic analysis as suggested by Braun & 
Clarke following their 6-phase guide for thematic analysis 
[34,35]. The thematic analysis was conducted deductively to 
identify data from existing collaboration theory in the literature 
[36,37]. Thus, emerging themes were arranged according to 
one of the six predefined theory-derived themes (see table 1). 
The derivation of the six themes from theory is described in the 
subsection “Theory” below. However, it was necessary to 
complement the analysis with an inductive thematic analysis, 
with more open coding, to accommodate themes that did not 
fit into the predefined theory-derived themes. The data were 
thus also searched for non-theory-derived factors affecting the 
collaboration. 
 
LVJL and LSN first coded the transcript from the first focus 
group interview individually based on the predefined themes. 
Disagreements identified were discussed until consensus was 
reached. Then, LVJL and GRH individually coded passages of the 
transcript from the second focus group interview. 
Disagreements were discussed until a consensus was reached. 
Finally, LVJL, LSN and GRH met and discussed the emerging 
themes. Subsequently, LVJL discussed the final themes, 
subthemes and descriptions based on both focus group 
interviews with GRH and LSN to ensure confirmability of the 
analysis and subsequently the results [35].   
 
Theory 
LVJL conducted a literature search in PubMed and Google 
Scholar, which resulted in the identification of three 
collaboration theories on factors influencing collaboration. The 
theories had to be specific to either intra- or interprofessional 
collaboration and on collaboration in general within a team. 
Two non-healthcare-specific theories were identified [37,38] 
alongside one healthcare-specific theory [36]. In the non-
healthcare-specific theory described by Mattessich et al., the 
authors identified no less than 19 different factors affecting 
collaboration, which was deemed too complex to apply for the 
analysis [38]. However, the factors that Mattessich et al. [38] 
described as affecting collaboration were comparable to many 
aspects with the other non-healthcare-specific theory by Patel 
et al. [37], which described eight factors. Thus, it was decided 
to use the non-healthcare-specific theory-derived factors 
described by Patel et al. [37] at the outset and to supplement 
and merge the theory with the factors described in the 
healthcare-specific theory by Morley et al. [36]. The merging of 
the two theories was deemed necessary for the resulting theory 
to fit the clinical and practice setting of HPs and CPs. The factors 
derived from the theories by Patel et al. [37] and Morley et al. 
[36] are listed in appendix II. The determinants from the theory 
described by Morley et al. were merged with the factors 
described in the theory by Patel et al. [37]. The merging resulted 
in six predefined themes used for the theoretic thematic 
analysis (see table 1). 
 
Clinical pharmacist 
service (CPS) provided 
at the acute ward.
Pharmacist note 
transfered to the 
community 
pharmacist.
The community 
pharmacist follows up 
with the patient 
based on the 
pharmacist note.
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Table 1: The six predefined themes used for deductive analysis after merging of the factors described in the non-healthcare  
specific theory  by Patel et al. [37] and the health-care specific theory by Morley et al. [36]:  
HP = Hospital Pharmacist, CP = Community pharmacist 
 
Name and definition of theme Example 
Context 
The organization and/or existing structure in which the collaboration has to be 
established. The context affects the opportunities for collaboration and new work 
tasks.  
The different clinical settings in the 
hospital and community pharmacy. 
Support 
Facilitators and/ or opportunities existing to support the collaboration and tasks. 
The time available in the community 
pharmacy or hospital pharmacy that can 
be used for the new collaboration and 
tasks. 
Tasks 
The (new) tasks and the type and structure thereof that will involve the 
collaboration. The complexity of the tasks highly affects how much collaboration 
is needed.  
The sharing of information between the 
hospital and community pharmacy can 
be seen as a new type of task. 
Communication  
The type, frequency and need for communication in the collaboration. Successful 
communication makes collaboration more effective.  
The frequency in which the HPs and CPs 
have to communicate for the 
collaborative tasks to be solved. 
Teams 
The nature and setup of the team that will collaborate, including the roles taken 
on by each team member and the understanding of each role in the team. 
Understanding the importance of and necessity of a role in a team affects the 
success of teamwork in the collaboration. 
Respect and trust between HPs and CPs. 
Individuals 
The individual collaboration skills of the individuals in the team. Psychological 
factors such as motivation, beliefs and experience also affect the success of the 
collaboration.  
The motivation for collaborating with 
HPs/CPs.  
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RESULTS 
Two focus group interviews were conducted in June 2017. They 
lasted 2 hours and 25 min and 2 hours and 43 min. The 
participants were seven pharmacists (three HPs and four CPs) 
and four pharmacists (two HPs and two CPs). The pharmacists 
were on average 36 [30.6; 41.6] years old, the majority were 
females (91.5%), and the HPs and CPs had an average of 5.2 
[2.9; 7.6, respectively] years of experience in total. 
 
Both groups of pharmacists were generally positive towards 
working intraprofessionally and expressed a willingness to 
collaborate across sector boundaries focusing on hospital-
discharged patients. Both groups of pharmacists were 
interested in understanding the views and perspectives 
expressed by one another.  
 
Three themes and seven subthemes (see figure 2) were 
identified. Two themes, “Individuals” and “Context” were 
theory-derived, while the theme “The hospital physicians and 
GPs as the focal points of the HPs’ and CPs’ work”, was specific 
for this type of pharmacist collaboration and did not fit into pre-
existing themes. In the following section, the three themes and 
subthemes will be presented.  
 
Figure 2: The three identified themes and subsequent subthemes. 
Abbreviations: CP = Community Pharmacist, HP = Hospital Pharmacist, GP = General Practitioner 
 
Context 
The context in which the collaboration was to be established 
was important for both groups of pharmacists. They identified 
limitations in the way they already worked in the community 
pharmacy and on the hospital wards. It was important for  
both groups to gain insight into these limitations, as these 
limitations affected the possibilities for a new intraprofessional 
collaboration.  
 
Prioritization of the new tasks in the intraprofessional 
collaboration 
Both groups of pharmacists had limited time and resources 
to manage their current workload, and they were used to 
prioritize what information to provide to the hospital physician 
and/or the patient. Accordingly, this prioritization would need 
to be carried out in the intraprofessional collaboration as well. 
” (…) if I am to inform this poor customer about six different 
drugs at once (…) I mean, it is difficult to talk about all that in 
just one conversation because they are able to remember what 
1% of what we tell them. “(CP-4) 
Although both groups of pharmacists asked for a prioritization 
in relation to tasks in the intraprofessional collaboration, the 
HPs expected the prioritization to be different from current 
practice. 
 
“Then, I just think about prioritizing because, when I prioritize, I 
do it with the hospital physician in mind. If I have to do that for 
a community pharmacist, then I would probably prioritize 
differently, I think.” (HP-2) 
 
Context
Subtheme I:
Prioritization of the 
new tasks in the 
intraprofessional 
collaboration.
Subtheme II: 
The lack of insight 
into the patient's 
hospital stay.
The hospital physicians 
and GPs as the focal 
points of the HPs' and 
CPs' work
Subtheme I:
The limitation of CPs 
and HPs are based 
on current roles and 
organizations.
Subtheme II: 
Lack of regular 
access to the GP 
gives the patients 
more responsibility.
Subtheme III:
Lack of support from 
the GPs on the work 
conducted by HPs 
and CPs.
Individuals
Subtheme I:
The motivation for 
working 
intraprofessionally.
Subtheme II: 
CPs' hesitancy 
toward the new 
tasks in the 
intraprofessional 
collaboration.
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The lack of insight into the patient's hospital stay limits the HPs’ 
and CPs’ abilities to give advice 
The HPs providing the CPS at the acute ward lack insight into 
what happens to the patients and their medications after they 
leave the acute ward for the bed unit. Because of this lack of 
knowledge, the pharmacists were afraid of confusing the 
patients. 
 
“(...) you don’t know what the hospital physician implements 
and doesn’t implement and then what? (…) Then, the 
community pharmacist at the community pharmacy has to 
convince the patient that something has to be changed in 
his/her medical treatment, even though a physician already 
decided nothing should be changed.” (HP-4) 
 
Insight into the work tasks of the other pharmacist group would 
make it easier for both groups to understand the possibilities 
for collaborating intraprofessionally and more easily build upon 
or supplement each other’s work.  
 
“I have only really worked in community pharmacy and 
sometimes, it is hard for me to understand what you, as hospital 
pharmacists, are really doing at the hospital (…) How can I at 
the community pharmacy also help get your interventions to the 
patients?” (CP-2) 
 
The hospital physicians and GPs as the focal points for the HPs’ 
and CPs’ work 
Both groups of pharmacists feel dependent on both the hospital 
physicians and GPs in their work because they need them to 
accept and implement their suggestions for changing the 
medication regimen. This dependency creates a strong focal 
point around the hospital physician and the GP in the work of 
both groups of pharmacists. 
 
The limitations of CPs and HPs are based on current roles and 
organizations 
Both groups of pharmacists acknowledged that the GPs and the 
hospital physicians are responsible for the medical treatment of 
the patient and are the only ones who can and should change 
or intervene in the medical treatment directly. Both groups of 
pharmacists see this dependency on the HPs and the GPs as 
limiting the success of an intraprofessional collaboration. If the 
hospital physicians and the GPs cannot be directly involved in 
the collaboration, the GPs should at least be informed about 
what happened to their patients at the community pharmacy.  
 
“I think it is really good, this pharmacist-to-pharmacist 
collaboration. But I am just still afraid that these physicians are 
sitting in the middle really. How do we move forward, right? (…) 
We [the pharmacists] can’t change the prescription (…) So I am 
just afraid about (…) that all these good intentions might just 
fall to the ground, because how do we get access to those 
physicians?” (HP-1) 
 
Lack of regular access to the GP gives the patients more 
responsibility 
Both groups of pharmacists have difficulty getting in contact 
with the GP. Therefore, an important aspect of 
intraprofessional collaboration should be the establishment of 
an easy way to get through to the GP with the medication 
changes proposed by either the HPs or the CPs. Both groups of 
pharmacists state that if it is impossible for them in the 
intraprofessional collaboration to get through to the GP, the 
patients should be responsible for communicating the 
suggestions for changes to the medical treatment made by HPs 
or CPs to the GP.  
 
“I also think it might be important that we agree upon who is 
responsible for implementing this intervention, if we agree that 
you [the HPs] send something to us, that we should make an 
intervention on (...) do we tell the costumer: ‘Be sure to talk with 
your GP about this’. Or do we directly contact [the GP]? (…) 
because otherwise, we will end up talking about something that 
could be a good idea, but then, it doesn’t go any further than 
that.” (CP-3) 
 
Lack of support from the GPs for the work conducted by HPs 
and CPs 
Both groups of pharmacists identified the lack of willingness 
from especially the GPs to collaborate. This lack of willingness 
is thought to occur because the GPs and the hospital physicians 
have a strong professional pride in their work and because the 
pharmacist profession has not branded itself enough. 
 
“(…) and then we are stuck again with the fact that we haven’t 
been good about communicating to others what we are doing 
and what we are capable of doing in relation to the physicians… 
so that they would understand that what we do is smart.”  
(CP-3) 
 
Individuals 
The individual factors affecting the intraprofessional 
collaboration were related to motivation and hesitancy. The 
two groups of pharmacists were motivated differently for 
establishing an intraprofessional collaboration as a 
consequence of the difference in the way they are working. 
Additionally, the CPs felt hesitant about conducting new tasks 
in relation to the intraprofessional collaboration. 
 
The motivation for working intraprofessionally 
Due to the differences in their work tasks, both groups of 
pharmacists are motivated differently. The CPs are highly 
motivated by getting feedback from patients, so they know that 
they are making a difference for the individual patient. The HPs 
are not in the same way in contact with the individual patient 
and do not get their work directly validated by the hospital 
physician. However, natural trust from HPs towards CPs already 
exists, as it already does from HPs towards hospital physicians. 
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“(…) we already write all this [to the hospital physician], where 
we hope that someone looks at it. And I am thinking that it 
would be in the same spirit, we would write to you [the CP] (…) 
Of course, it would be nice to have feedback, but I would also 
think that I had the trust, the faith, that you [the community 
pharmacists] would do something good with it really.” (HP-2) 
 
CPs’ hesitancy towards the new tasks in the intraprofessional 
collaboration 
CPs felt hesitant about the new tasks related to the 
intraprofessional collaboration. This sentiment was especially 
evident when the HPs and the CPs discussed whether the new 
collaboration should lead to a new service or a consultation 
offered to hospital-discharged patients. To overcome this 
hesitancy, the CPs tried to relate to and make the new service 
look similar to an existing service. 
  
“I am thinking it [the new service] could very much be like the 
New Medicines Service (…). Now, we just have some more 
information. (…) I mean it is positive, it is easier to fit into the 
community pharmacy.” (CP-5) 
  
DISCUSSION 
In this study, we found that both HPs and CPs are generally 
positive towards intraprofessional collaboration at the 
interface between hospital and primary care. However, both 
groups of pharmacists question whether intraprofessional 
collaboration will actually change current practice. While 
intraprofessional collaboration may possibly solve some issues 
related to the transition of care, pharmacists acknowledge their 
dependency on physicians (either GPs or hospital physicians) to 
implement their work. This finding is highly relevant when 
developing the intraprofessional collaboration further, as this 
directly questions the implementation ability and feasibility of 
a solely intraprofessional collaboration between pharmacists.  
 
The results show that a factor affecting the success and 
willingness to collaborate for the pharmacists was related to 
having insight into the work of the other pharmacist group and 
into the patient’s hospital stay. Currently, the HPs in the 
Zealand region are only involved during the patients’ admission 
process at the hospital. Meanwhile, CPs are only involved in 
dispensing medication postdischarge with no knowledge of 
what happened during the hospital stay. The need for more 
insight expressed by CPs is also reported in the literature, 
stating that community pharmacists lack sufficient information 
on hospital-discharged patients [39]. 
 
In other countries, HPs are increasingly involved in more than 
just fragments of the hospital stay and are a part of the 
interdisciplinary health care teams routinely conducting 
medication reviews at admission, during the hospital stay and 
at discharge [40,41]. A recent Danish study showed a significant 
effect on readmissions when the involvement of a pharmacist 
was multifaceted, i.e., when the HP was involved both during 
the hospital stay and at discharge [8]. In the Netherlands, 
Ensing et al. reported a new intervention that also involved 
collaboration between HPs and CPs, enabling staff at the 
community pharmacy to gain insight into what happened with 
the patient’s medication throughout the hospital stay. 
However, the referral and the collaboration were established 
between a pharmacist in the discharge process and the 
community pharmacist. The CPs conducted a follow-up with the 
patient, where they identified several drug-related problems 
post discharge. These drug-related problems were identified 
because the CPs were aware of medication changes and 
pending drug-related problems from the hospital stay - 
information provided by the HPs [24,42]. In the present study, 
both HPs and CPs were concerned that the HPs do not have 
insight into what happened with the patient after admission. 
This concern combined with the above mentioned studies 
shows that a cross-sectorial intraprofessional collaboration 
could be made more relevant in relation to enhancing 
medication safety for discharged patients if the collaboration 
could be established between a HP in the discharge process and 
a CP at the community pharmacy. 
 
In this study, the hospital physicians and the GPs seemed to be 
the focal points of the pharmacists’ work, which is right now 
limiting both groups of pharmacists’ tasks even in a solely 
intraprofessional collaboration. Missing access to and support 
from the GPs in general suggest that the interprofessional 
collaboration still has to be optimized, especially in relation to 
the CPs. Based on these results, one might hypothesize that a 
fruitful intraprofessional collaboration comes from a well-
established interprofessional collaboration. Nørgaard et al. 
suggested that for the community pharmacy to expand their 
role, CPs would have to focus more on interprofessional 
collaboration with GPs [43]. However, Gobis et al. also argued 
that too much effort has been put into widening 
interprofessional collaboration while HPs and CPs are taking 
very divergent paths, almost becoming two different 
professions due to less or too little focus on intraprofessional 
collaboration [21]. The divergent paths taken by the HPs and 
the CPs are also described by Taylor et al., who claim that HPs 
are becoming increasingly specialized [44]. According to Gobis 
et al., this specialization results in a siloed and fragmented 
approach to patient care opposed to seamless, coordinated and 
continuous patient care, which is advocated to reach optimal 
patient care [44]. The divergent paths taken by HPs and CPs 
might also be why HPs and CPs lack knowledge about each 
other’s work, as our findings suggest.  
 
Important measures may be implemented to create a fruitful 
offset for intraprofessional collaboration. It is necessary to 
introduce intraprofessional pharmacist collaboration during 
pharmacy education. The WHO has stressed the need for 
interprofessional education, also known as IPE [45], and this has 
been implemented in pharmacy education in some countries 
(e.g., USA and UK), where pharmacists, nurses and physicians 
work with clinical cases to enhance their interprofessional skills 
[46]. Emphasizing intraprofessional collaboration during the 
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pharmacist curriculum is also vital, as this would enable 
pharmacists to seek collaboration with pharmacists in other 
settings after graduation, and they would have more 
opportunities to address challenges regarding patients 
intraprofessionally. After graduation, it is important for the 
profession to foster awareness of the different work tasks 
conducted by pharmacists in various settings and specialties. 
This could be facilitated by allowing pharmacists to shadow 
each other’s work and to create networks with the aim of 
sharing knowledge between HPs and CPs. The new insight may 
provide CPs and HPs with new ideas for collaboration to 
enhance medication safety at care transitions. 
  
In the present study, we found that the HPs an CPs lacked 
knowledge about each other’s clinical services and 
competencies. Furthermore, a lack of support from other 
healthcare professionals (i.e., physicians) detracted 
intraprofessional collaboration. This was also shown in a survey 
by Penm et al. [47], where pharmacists were highly affected by 
the views of other professions in relation to expansion of their 
role. It is surprising to see in our study that even when focusing 
on intraprofessional collaboration, CPs and HPs are 
intentionally or unintentionally affected by physicians in patient 
care. Thus, our study also indicates that to create an 
environment conducive to intraprofessional collaboration 
among pharmacists, it is necessary to change the views of 
pharmacists themselves regarding their own competencies and 
abilities. 
 
Strengths and limitations 
In the present study, both the facilitator and the moderator 
(LVJL and LSN) were trained pharmacists and thus had insight 
and knowledge about the pharmacy field, strengthening the 
study results. To overcome the possibility that too much insider 
knowledge might be brought into the analysis of data, another 
health care professional (GRH) was involved in the analysis, 
securing confirmability in the analysis phase [32]. Additionally, 
preconceptions were discussed prior to the first focus group 
between the moderator and facilitator, to make sure these 
were unintentionally taken into the focus groups and affected 
the results.  After each focus group, the moderator and 
facilitator conducted a debriefing session. After the first focus 
group, better probes to induce discussion were added to the 
interview guide. Additionally, the introduction and information 
about the study was shortened to make space for more fruitful 
discussions.  
 
In the present study, the derived themes from existing 
collaboration theory fit our study results to only a minor extent. 
Only two out of six of the theory-derived themes were 
identified in our data namely “Context” and “Individuals”. 
“Context” seemed to be an important theme affecting the 
establishment of intraprofessional collaboration, and it might 
be that the HPs and CPs had to comprehend the context and 
the differences in context prior to being able to discuss other 
themes, such as tasks, communication and support. However, 
the deductive analysis was supplemented with an inductive 
analysis, allowing for new themes not based on theory to arise. 
This process highly strengthened the output of the analysis and 
subsequently the credibility of the results.  
The study also had limitations. We invited only HPs employed 
in one hospital pharmacy in one of the five regions in 
Denmark, which limited the number of HP informants available. 
Consequently, we ran out of HP informants for more focus 
groups but had several CP participants available. This limitation, 
together with the number of focus groups held, might affect the 
credibility of the study results, as the number of focus group 
interviews conducted was a consequence of the available pool 
of informants and not a matter of reaching data saturation 
[35].   
 
Future studies should preferably aim at conducting more focus 
groups with the inclusion of HPs and CPs from different 
geographical regions to enhance saturation and transferability 
of the study results [34]. Additionally, it is relevant to study 
whether successful and well-implemented interprofessional 
collaboration between physicians, HPs and CPs can enable 
better intraprofessional collaboration. Lastly, piloting a 
collaboration between HPs and CPs and exploring HPs´ and CPs´ 
views on a specific collaboration in real world practice is 
recommended. 
 
CONCLUSION 
Hospital pharmacists (HPs) and community pharmacists  
(CPs) are highly influenced by the context in which their  
work is embedded in establishing a new intraprofessional 
collaboration. Additionally, they miss insight into each other’s 
work in order to be able to see the full potential of working 
intraprofessionally. While HPs and CPs are in general positive 
towards intraprofessional collaboration, physicians are 
important key professionals that both HPs and CPs depend on 
when they conduct their work. This dependency of physicians 
seems to affect the pharmacists’ views on the capability and 
success of a solely intraprofessional collaboration. Future 
studies should aim at piloting a specific collaboration between 
HPs and CPs and explore their views and perspectives toward 
collaborating in real world practice.  
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Appendix I 
 
Interview guide used in the focus group interviews. 
Subject Aim(s) Probe(s) Method 
1. Problem and 
solution 
identification 
To make the pharmacists identify 
which problems and solutions the 
participants consider there are in 
relation to the transition of care 
and to assess whether they agree 
on the problems and solutions. 
 Were there any problems 
presented by the other 
participants that you were 
not aware of, and if so, what 
are they? 
  
  
The participants individually 
wrote down for 5-7 minutes 
what they considered the 
three major problems and 
solutions on paper.  
 
This was followed by a plenary 
discussion. 
2. The 
collaboration 
framework 
To understand the views of the 
participants on the new 
collaborative tasks and the 
collaboration itself. 
 What is the main content of 
the best collaboration? 
 What are the strengths and 
weaknesses of the 
collaboration? 
 What are the possibilities 
and threats? 
 Is it possible to solve some of 
the problems related to the 
transition of care through 
collaboration? Why/why 
not? 
  
Plenary discussion. The 
facilitator briefly described 
the collaboration model and 
an example of a pharmacist 
note. 
  
  
3. The aim and 
tasks of the 
collaboration 
To understand what facilitators 
and barriers that arises from the 
collaboration framework as seen 
by HPs and CPs.  
 What are the facilitators and 
barriers for the collaboration 
to succeed?  
 Which conditions have to be 
met for the collaboration to 
be established? 
 What should be the aim of 
the collaboration? 
Plenary discussion. A 
discussion prompted by 
examples of themes on the 
table they could discuss. 
4. Outro To ensure that all areas of 
importance to the participants 
were discussed. 
  
 Are there any unclear areas 
or any areas we have not 
touched upon?  
  
Plenary discussion. 
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APPENDIX II 
Factors described affecting collaboration based on the non-healthcare-specific theory by Patel et al.  
(blue) [37] and the health-care-specific theory by Morley et al. (red) [36]. 
 
 
Patel et al (blue) suggests eight factors affecting the success of collaboration, each divided into different subfactors. Two examples of subfactors per 
factor are presented in this figure. In the original article, all the subfactors for each factor are described [37]. 
Morley et al. (red) suggest three determinants affecting the success of inter-professional collaboration, each supported by different specific 
determinants [36]. 
 
 
 
 
 
Structural Determinants 
(Opportunity) 
Time, space, tools, procedures 
 
Educational determinants 
(Ability) 
Interprofessional collaborative skills, 
shared language 
 
Physiological determinants 
(Willingness) 
Safety, collegiality, role valuing 
 
 
Context 
Culture, Organizational 
structure 
 
Teams 
Roles, common ground 
 
Support 
Tools, resources 
 
Interaction processes 
Learning, communication 
 
Tasks 
Type, structure 
 
Individuals 
Skills, well-being 
 
Overarching factors 
Trust, experience 
